CLINICAL_TRIALS
trial_result
· 2015-05-29
Clinical Trial Update: Capecitabine vs. S-1 in Unresectable or Recurrent Breast Cancer [Phase 2]
Summary
Phase 2 trial comparing capecitabine with S-1 in unresectable or recurrent breast cancer has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Japan Breast Cancer Research Network | Conditions: Breast Neoplasms | Phase 2 | Status: COMPLETED | Results posted: 2015-05-29